Mostrando 4 resultados de: 4
Filtros aplicados
Subtipo de publicación
Article(4)
4(1H)-quinolones with liver stage activity against Plasmodium berghei
ArticleAbstract: With the exception of primaquine, tafenoquine, and atovaquone, there are very few antimalarials thatPalabras claves:Autores:Cross R.M., Fabián E. Sáenz, Kyle D.E., Lacrue A.N., Manetsch R., Monastyrskyi A., Mutka T.S., Stein S., Udenze K.O.Fuentes:googlescopusNovel 4-aminoquinoline analogs highly active against the blood and sexual stages of Plasmodium in vivo and in vitro
ArticleAbstract: New drugs to treat malaria must act rapidly and be highly potent against asexual blood stages, wellPalabras claves:Autores:Fabián E. Sáenz, Kyle D.E., Mutka T.S., Oduola A.M.J., Udenze K.O.Fuentes:googlescopusOrally bioavailable 6-chloro-7-methoxy-4(1 H)-quinolones efficacious against multiple stages of plasmodium
ArticleAbstract: The continued proliferation of malaria throughout temperate and tropical regions of the world has prPalabras claves:Autores:Bathurst I., Burrows J.N., Charman S.A., Cross R.M., Fabián E. Sáenz, Flanigan D.L., Fronczek F.R., Guida W.C., Kyle D.E., Lacrue A.N., Maignan J.R., Manetsch R., Monastyrskyi A., Mutka T.S., Shackleford D.M., White K.L., Wojtas L.Fuentes:googlescopusQuinolone-3-diarylethers: A new class of antimalarial drug
ArticleAbstract: The goal for developing new antimalarial drugs is to find a molecule that can target multiple stagesPalabras claves:Autores:Angulo-Barturen I., Avery V.M., Bathurst I., Burrows J.N., Charman S.A., Cross R.M., Delves M.J., Duffy S., Fabián E. Sáenz, Ferrer S., Forquer I.P., Gamo F.J., Guy R.K., Herreros E., Jiménez-Díaz M.B., Kelly J.X., Kocken C.H.M., Kyle D.E., Lacrue A.N., Li Y., Manetsch R., Marfurt J., Mather M.W., Morrisey J.M., Mutka T.S., Nilsen A., Noviyanti R., Price R.N., Riscoe M.K., Ryan E., Sanz L.M., Sebayang B.F., Shackleford D.M., Siegl P., Sinden R.E., Steuten J., Vaidya A.B., White K.L., Winter R.W., Wirjanata G., Zeeman A.M.Fuentes:googlescopus